MYCN and neuroblastoma: This suggests that BV6 is able to reduce XIAP expression but with less potency than A4 and B3, and may explain why certain neuroblastoma cell lines remain sensitive to BV6 while lines with high XIAP and MYCN expression only respond to A4 and B3.